These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36707090)

  • 21. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
    Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
    Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry.
    Dain AS; Diorio C; Fisher BT; Hankins JS; Witmer CM; Boustany M; Burton M; Ferrolino J; Sadaf S; Ross HS; Maron G;
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30909. PubMed ID: 38469996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020.
    Pathak EB; Salemi JL; Sobers N; Menard J; Hambleton IR
    J Public Health Manag Pract; 2020; 26(4):325-333. PubMed ID: 32282440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
    Feldstein LR; Rose EB; Horwitz SM; Collins JP; Newhams MM; Son MBF; Newburger JW; Kleinman LC; Heidemann SM; Martin AA; Singh AR; Li S; Tarquinio KM; Jaggi P; Oster ME; Zackai SP; Gillen J; Ratner AJ; Walsh RF; Fitzgerald JC; Keenaghan MA; Alharash H; Doymaz S; Clouser KN; Giuliano JS; Gupta A; Parker RM; Maddux AB; Havalad V; Ramsingh S; Bukulmez H; Bradford TT; Smith LS; Tenforde MW; Carroll CL; Riggs BJ; Gertz SJ; Daube A; Lansell A; Coronado Munoz A; Hobbs CV; Marohn KL; Halasa NB; Patel MM; Randolph AG; ;
    N Engl J Med; 2020 Jul; 383(4):334-346. PubMed ID: 32598831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.
    Wu X; Wang L; Shen L; He L; Tang K
    J Hematol Oncol; 2022 Jun; 15(1):81. PubMed ID: 35710431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel.
    Gordon OM; Terpilowski M; Dulman R; Keller MD; Burbelo PD; Cohen JI; Bollard CM; Dave H
    Pediatr Hematol Oncol; 2022 Sep; 39(6):571-579. PubMed ID: 35135442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City.
    Kaushik S; Aydin SI; Derespina KR; Bansal PB; Kowalsky S; Trachtman R; Gillen JK; Perez MM; Soshnick SH; Conway EE; Bercow A; Seiden HS; Pass RH; Ushay HM; Ofori-Amanfo G; Medar SS
    J Pediatr; 2020 Sep; 224():24-29. PubMed ID: 32553861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
    van Doesum JA; Salmanton-García J; Marchesi F; Di Blasi R; Falces-Romero I; Cabirta A; Farina F; Besson C; Weinbergerová B; Van Praet J; Schönlein M; López-García A; Lamure S; Guidetti A; De Ramón-Sánchez C; Batinić J; Gavriilaki E; Tragiannidis A; Tisi MC; Plantefeve G; Petzer V; Ormazabal-Vélez I; Marques de Almeida J; Marchetti M; Maertens J; Machado M; Kulasekararaj A; Hernández-Rivas JÁ; Gomes da Silva M; Fernández N; Espigado I; Drgoňa Ľ; Dragonetti G; Metafuni E; Calbacho M; Blennow O; Wolf D; van Anrooij B; Nunes Rodrigues R; Nordlander A; Martín-González JA; Liévin R; Jiménez M; Gräfe SK; García-Sanz R; Córdoba R; Rahimli L; van Meerten T; Cornely OA; Pagano L
    Blood Adv; 2023 Jun; 7(11):2645-2655. PubMed ID: 37058479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience.
    Walker B; Zimmer AJ; Stohs EJ; Lunning M; Lyden E; Abbas A
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14191. PubMed ID: 37987114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes.
    Guo W; Zheng Y; Feng S
    Front Cell Infect Microbiol; 2023; 13():1207225. PubMed ID: 37928188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
    COVIDSurg Collaborative
    Lancet; 2020 Jul; 396(10243):27-38. PubMed ID: 32479829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica.
    Bisogno G; Provenzi M; Zama D; Tondo A; Meazza C; Colombini A; Galaverna F; Compagno F; Carraro F; De Santis R; Meneghello L; Baretta V; Cesaro S
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):530-534. PubMed ID: 32652521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
    Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
    Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies.
    Zhu F; Wei G; Liu Y; Zhou H; Wu W; Yang L; Huang H; Hu Y
    Cell Transplant; 2021; 30():9636897211025503. PubMed ID: 34144648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
    Khawaja F; Papanicolaou G; Dadwal S; Pergam SA; Wingard JR; Boghdadly ZE; Abidi MZ; Waghmare A; Shahid Z; Michaels L; Hill JA; Kamboj M; Boeckh M; Auletta JJ; Chemaly RF
    Transplant Cell Ther; 2023 Jan; 29(1):10-18. PubMed ID: 36273782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.